Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Balance Sheet
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H's total assets for Q1 2025 were ¥17.55B, an increase of 1.17% from the previous quarter. HK:9989 total liabilities were ¥5.21B for the fiscal quarter, a 1.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Total Assets
¥ 17.34B
¥ 19.20B
¥ 20.81B
¥ 19.11B
¥ 19.03B
Total Liabilities
¥ 5.14B
¥ 7.22B
¥ 8.41B
¥ 7.58B
¥ 7.34B
Total Equity Gross Minority
¥ 12.20B
¥ 11.99B
¥ 12.41B
¥ 11.52B
¥ 11.69B
Other Metrics
Currency in CNY
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Debt to Assets